Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would love for the company to say anything at this point. I still believe our best days are to come. When we get through a few of these phase 1s I believe we will be a multi dollar stock. Long term with the cancer applications as well as the ALS potentials this stock could be a powerhouse.
It seems to be solid science this company is based on, but due to the way the are going about financing it is going to take some time.
I've been in DOGE for a few weeks now, but also have been in the past. Never thought about looking around here for a board. Should have known lol
I hope that is the case. I did email the company, which in the past has been very responsive to my emails. I wish I could take the email back as I stated in the email that not updating the stockholders on the move to non reporting status was "unacceptable". I hope I did not burn a bridge there. I should have been my normal diplomatic self. Anyway I hope we hear something soon. I do have an idea on what is going to happen.
In short I think it is positive, but I think they are saving money for now to use money to continue phase 1 for both IPF and radiation oncology.I think once they make it fully through phase 1 they will go for funding, which will require them to uplist and report earnings again. I think once those phase 1s are reported as a success, which I believe they will there is a good chance that we will next we hear they are are uplisting to a new exchange while restructuring to the stock.
just speculation....
I really think the company should have honestly explained to us the path forward. What was/is in the works and what we can expect.
This is painful.
Well I picked up a few more...
I'm holding and waiting too. I agree this one you just have to let play out and let it exerciser your patient. They are still moving forward and I believe 2018 will be an exciting year.
Someone got a nice buy this morning. Can't wait for this thing to grow legs. It should be a fun ride.
I hope this continues. I expect we should be getting some news soon. It has been a while.
Well not exactly, but for the most part yes. There are safety studies run on healthy patients, which was reported recently.
doris over at the aols yahoo board has had some interesting insight over the years. Here is the text of her last post:
We are just waiting for the right people to find out about this stock. It is trading way under value right now.
yes indeed. I would love to see the volume continue before the obvious move up that is going to happen here.
Good news today, slow and steady! I would have liked more guidance on next steps and where we are headed next.
Now that I have reread everything, I don't think there is anything we are expecting from the FDA at the 60 day mark. As I read it we already got fast track designation.
I am still holding and adding small chunks at this price.
Was out of pocket all day. I am a little surprised this did not do better. I really would have expected this would put us back into the .20s maybe even further. I am long with my position so I am not in a huge rush.
Wow someone stepping out the last few days.
I was hoping to find more info here. pretty quiet.
Now this is positive news:
"In addition, we are submitting proposals to and have received indications of interest from other government agencies to expand the funding of AEOL 10150 as a medical countermeasure against the pulmonary effects of radiation exposure and sulfur mustard gas exposure."
https://finance.yahoo.com/news/aeolus-announces-second-quarter-financial-210000113.html
I wondered the same thing. I wonder if someone knows something... Guess we will have to wait and see.
Nice hit at the ask. Now we just need some bid support.
Wow that is coming directly from Dr. Rick Bright, the director of BARDA. That makes me think everything is not finished with BARDA. The company has been quiet and has not returned by last email, which is unusual as we have an email tread that goes back a couple years. I hope they are in talks to get to redo their presentation.
I emailed the company to see if they would still be presenting today. They never got back to me. Maybe he is traveling and just did not have time. I don't see them listed on the microcap website.
I just have to think there must be something political going on here. Without barda this is a different kind of investment. I just don't have enough info to really understand what was the real cause of the cancellation. I do hope they April 4th meeting still happens or either a clear PR going into more info.
They might should have a conference call to explain more.
Wow not the news we were looking for. I don't really know what to think. I wounder if there is something political going on here.
Thanks to the user who sent me a PM letting me know I could still be a mod. I guess when my subscription lapsed a few months back the removed me as a mod, but I was still able to request to be added back.
If I were still a paying member of ihub and still the mod I would sticky your post. Those are the exact feelings I have about this company. I think so many people are missing an amazing opportunity here.
Aeolus Pharmaceuticals AOLS (http://www.aolsrx.com/) is worth a second look? They have a $118 million dollar R&D contract through BARDA. They are undergoing a phase 1 trail with the new formulation of the less expensive AEOL 10150. This trial will only last a month or so. There will then be a multi dose phase 1 in healthy patients. These trials were already done under the old more expensive formulation. After that the company will use the data from this study and it will be included in the Company's pre-Emergency Use Authorization application in Lung-ARS.
Here is the most recent PRs: http://www.aolsrx.com/news/press-releases
I wish I was holding more at this point. I sold half my shares a year or so back on a nice profit. I still have a strong position, but this company is solid and I wish I had more. lol
This stock is so undervalued it is not even funny. Looks like the deeper pockets are starting to move into this one. Really nice and steady move up.
If you want a real company that is making significant headway and is closing in on a $330+ million contract with the federal government then check out AOLS.
I have been holding this one for a couple years and it is a long term position for me due to what they are putting together. They do not dilute this stock and have not for a long time.
Check out today's PR: http://ir.aolsrx.com/press-releases/detail/1280
Also they are undergoing a phase 1 trial right now that moves them to the edge of getting their drug added to the strategic stockpile. All of their funding for research has come from the federal government. That contract is worth $111 million. Do your DD.
I think we are headed back to the .50 range in the short term. This should really be interesting over the next couple months.
DUVT has not run in a while... would go to a penny with a little buying. It is a dormant pharma company
Thank I had not seen that. Here is the link if anyone else wants to see it.
https://www.ncbi.nlm.nih.gov/pubmed/28208025
Well I am just looking for a way to get in on Go-Jek and the only publicly held company I could find was KKR. I was just wondering if they disclosed their holding of go-jek and what percentage it equated to. I don't expect go-jek to make it in the US, but I think it could spread quickly throughout much of Asia.
Do we know how much they invested in Go-Jek?
Phase 1 on healthy patients to being soon. PR today
http://finance.yahoo.com/news/aeolus-initiates-phase-1-study-130000808.html
I agree. I think 2017 is the year. I expect we should hear some news soon.
If you have not looked at the latest investor presentation is has some interesting info. When the company gets a $300m order under barta this stock price will seem ridiculously cheap.
http://content.stockpr.com/aolsrx/media/04530e34d78653e8343cea2f2058258e.pdf